LON:OOA Octopus AIM VCT (OOA) Share Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free OOA Stock Alerts GBX 61.50 0.00 (0.00%) (As of 04/18/2024 01:46 AM ET) Add Compare Share Share Today's Range 61.50▼ 61.5050-Day Range 57▼ 62.1052-Week Range 57▼ 73.25Volume100 shsAverage Volume17,019 shsMarket Capitalization£109.84 millionP/E RatioN/ADividend Yield8.13%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendInsider TradesStock AnalysisChartCompetitorsDividendInsider Trades Get Octopus AIM VCT alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Octopus AIM VCT Stock (LON:OOA)Octopus AIM VCT PLC is a venture capital trust specializing in investments in AIM or PLUS quoted companies. The fund seeks to allocate approximately 80 percent of its funds to qualifying investments in companies quoted on AIM or OFEX and the balance of 20 percent to non-qualifying Investments.Read More OOA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OOA Stock News HeadlinesJanuary 27, 2023 | ftw.usatoday.comDeadly octopus is served to a hot pot diner; ‘Can it be cooked?’December 14, 2022 | finance.yahoo.comNet Asset Value(s) - ReplacementApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.November 15, 2022 | finance.yahoo.comDIRECTOR / PDMR NOTIFICATIONNovember 15, 2022 | finance.yahoo.comCorrection: Issue of Equity and Total Voting Rights - replacementAugust 29, 2022 | reuters.comOctopus AIM VCTJuly 1, 2022 | finance.yahoo.comPurchase of Own Securities and Total Voting Rights - ReplacementJanuary 5, 2022 | investing.comOctopus Aim Vct Plc (OOA)April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.January 1, 2022 | markets.businessinsider.comOctopus AIM VCT PLC : Total Voting Rights and CapitalOctober 28, 2021 | markets.businessinsider.comOctopus AIM VCT PLC : Half-year report and dividend declarationOctober 26, 2021 | finance.yahoo.comHalf-year report and dividend declarationOctober 25, 2021 | markets.businessinsider.comOctopus AIM VCT PLC : Correction: Issue of Equity and Total Voting RightsOctober 14, 2021 | finance.yahoo.comCorrection: Issue of Equity and Total Voting RightsSeptember 14, 2021 | markets.businessinsider.comOctopus AIM VCT PLC : Close of Offers to Further ApplicationsSeptember 13, 2021 | finance.yahoo.comClose of Offers to Further ApplicationsSeptember 9, 2021 | finance.yahoo.comOffer for Subscription - Over-Allotment FacilityJuly 24, 2021 | markets.businessinsider.comOctopus AIM VCT PLC : Result of AGMJuly 24, 2021 | markets.businessinsider.comOctopus AIM VCT PLC : Intention to FundraiseJuly 22, 2021 | finance.yahoo.comIntention to FundraiseSee More Headlines Receive OOA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Octopus AIM VCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:OOA CUSIPN/A CIKN/A Weboctopusinvestments.com Phone+44-20-74227830FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-33,410,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-21.60% Return on Assets-13.40% Debt Debt-to-Equity RatioN/A Current Ratio45.83 Quick Ratio35.15 Sales & Book Value Annual Sales£-30,130,000.00 Price / Sales-3.65 Cash FlowGBX 15.46 per share Price / Cash Flow3.98 Book ValueGBX 79 per share Price / Book0.78Miscellaneous Outstanding Shares178,600,000Free FloatN/AMarket Cap£109.84 million OptionableNot Optionable Beta0.51 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesNicola BoardCompany SecretaryRoger J. SmithNon-Executive Independent Chairman of the BoardJoanne ParfreyNon-Executive DirectorNeal Ransome (Age 55)Non-Executive Director Stephen J. Hazell-Smith (Age 59)Non-Executive Independent Director Key CompetitorsSchroders Capital Global Innov TrustLON:INOVNorthern Venture TrustLON:NVTMolten Ventures VCTLON:MVCTPuma VCT 13LON:PU13Income & Growth VCTLON:IGVView All CompetitorsInsidersNeal RansomeBought 16,068 shares on 11/9/2023Total: £1.08 M ($67.00/share)View All Insider Transactions OOA Stock Analysis - Frequently Asked Questions How have OOA shares performed in 2024? Octopus AIM VCT's stock was trading at GBX 60 at the start of the year. Since then, OOA stock has increased by 2.5% and is now trading at GBX 61.50. View the best growth stocks for 2024 here. How often does Octopus AIM VCT pay dividends? What is the dividend yield for Octopus AIM VCT? Octopus AIM VCT announced a dividend on Wednesday, November 8th. Investors of record on Thursday, December 21st will be paid a dividend of GBX 2.50 per share on Friday, January 12th. This represents a dividend yield of 4.17%. The ex-dividend date is Thursday, December 21st. The official announcement can be viewed at this link. Read our dividend analysis for OOA. Is Octopus AIM VCT a good dividend stock? Octopus AIM VCT (LON:OOA) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 7.94%. OOA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for OOA. How do I buy shares of Octopus AIM VCT? Shares of OOA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OOA) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Octopus AIM VCT Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.